Microomics Systems S.L., a leading Spanish metagenomics company and a leading partner of comprehensive microbiome analysis services, has announced a restructure of its executive team in order to embark on a new growth phase.
Co-founder, and current CEO, Pedro González Torres will take on the role of Chief Scientific Officer (CSO), leading the company’s scientific and technical strategy, driving the development of new services and metagenomic solutions. This will expand the portfolio and consolidate Microomics’ position as a key partner in microbiome analysis.
Having guided the company from its beginnings to become a leading business, Pedro is handing over executive leadership to Jordi Navarro Oller, who joined as CEO last March. Jordi has 30 years’ experience in the healthcare and life sciences industry, having developed his career at companies including Bio-Rad, Amersham Pharmacia Biotech, Siemens Healthineers and Grifols. His strong track record in commercial leadership, both nationally and internationally, will be instrumental in accelerating Microomics’ expansion into new markets.
This new structure will enable Microomics to prepare for a period of strategic growth and strengthen its position and capabilities to innovate in the microbiome analysis field.